Sharon Virag compensation by year
NEOGENOMICS Summary Compensation Table · all 2 fiscal years held| Component | FY2018 | FY2019 |
|---|---|---|
| Salary | $298,462 | $257,723 |
| Bonus | $120,000 | $0 |
| Stock awards | $0 | $214,502 |
| Option awards | $485,100 | $386,597 |
| Non-equity incentive | $190,000 | $182,823 |
| Pension and deferred compensation | $0 | $0 |
| All other | $0 | $0 |
| Total | $1,093,562 | $1,041,645 |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: NEOGENOMICS INC DEF 14A filed April 15, 2021, accession 0001193125-21-117812, and prior-year filings.
How this page was built: the NEOGENOMICS INC filed document, accession 0001193125-21-117812. Every figure is read from that document and cited to the page and table it appears in. Filed April 15, 2021.
Equity holdings
unvested awards at FY2019 year-end| Type | Unvested units | Value at year-end | Exercise price |
|---|---|---|---|
| RSU | 2,736 | $80,028 | — |
| Option | 64,167 | — | $8.22 |
| Option | 16,724 | — | $19.60 |
Per the Outstanding Equity Awards at Fiscal Year-End table in NEOGENOMICS INC's FY2019 proxy; value at the fiscal year-end close, as the company printed it.
NEOGENOMICS’s named executive officers, FY2019
as the company reported each| Named executive officer | Role | FY2019 total |
|---|---|---|
| Douglas VanOort | Chairman of the Board & Chief Executive Officer | $3,648,732 |
| Robert Shovlin | President of Clinical Services | $1,284,099 |
| Lawrence Weiss | Chief Medical Officer | $1,183,674 |
| George Cardoza | President of Pharma Services | $1,107,374 |
| Sharon Virag · this page | Chief Financial Officer | $1,041,645 |
| Kathryn McKenzie | Vice President and Chief Accounting Officer (Principal Financial Officer) | $524,844 |
The full NEOGENOMICS compensation record
free company briefThis page is one person within NEOGENOMICS's record. The company brief lists every named executive, each linking to their own page.
Peer companies
named in the NEOGENOMICS proxy · each links to its own free briefCompensation, the day it’s disclosed
The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.
How this record is built
Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are NEOGENOMICS's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.